Congress And Regulators Slow To Respond To Drug Pricing And Shortage Problem | Latest News RSS feed

Congress And Regulators Slow To Respond To Drug Pricing And Shortage Problem - Latest News


Congress and regulators slow to respond to drug pricing and shortage problem

The views expressed by contributors are their own and not the view of The Hill Hospitals, doctors, and their patients are confronting two related drug access problems that should be unimaginable in Am... read more

Subsidies and Price Controls Aren't the Answer to Skyrocketing Prescription Drug Prices

Despite what the president would have you believe, the problem of high drug prices is not one with a simple solution. Subsidies and price controls, options that Trump seems to favor, could slow innova... read more

Drug prices going up despite Trump promise

The median price cut this June and July was 11 percent, much smaller than in comparable periods in prior years. The AP also asked 24 large drug companies this summer if they planned to cut drug prices ... read more

Looking for another news?


Drugmaker under fire for taxpayer-funded cancer drug that costs $129,269 a year

Despite its considerable power, the National Institutes of Health has declined five petitions requesting its march-in rights be used as an antidote to high drug prices or shortage problems ... the let... read more


FDA partly to blame in EpiPen price debacle

A major problem ... drugs already sold in countries with regulatory systems comparable to our own." The FDA already eases approval of some imports if it is to alleviate a drug shortage. Little to noth... read more

Drug shortages hit an all-time high

The only problem? Doxil wasn’t available. It is one of the drugs on the drug shortage ... or price gouging in these essential drug markets.” President Obama did sign an executive order this past Octob... read more

Ryan: 'Compromise' in the works for controversial drug pricing bill

ADVERTISEMENT Ryan’s remarks, made at a conference hosted by the law firm BakerHostetler, came in response ... s drug pricing plan, unveiled last week. While most of the actions Trump unveiled are adm... read more

The solutions to America's drug cost dilemma (and why they won't happen)

Congress has been grilling drug company executives over their big price hikes. Democratic presidential nominee ... He served as managing editor of Modern Healthcare from 2013 to 2015. His more than th... read more

Pharma group punches back on drug prices as pressure rises

A top pharmaceutical lobbying group will begin a counteroffensive against scrutiny of industry pricing practices, responding to ... were lambasted by Congress this year for their practice of sharply r... read more

GPOs fuel drug shortages [Commentary]

Most of the nearly 300 drugs in short supply are sterile injectables, including chemotherapy agents, antibiotics, medications for anesthesia and pain relief and intravenous nutrients. Prices ... arm o... read more

Critical Condition: Inside Pfizer’s Drug Supply Problem

Because today I don’t have another drug to give you.’” The problem is testing health care networks, large and small. Chris Snyder, Cleveland Clinic’s seasoned drug shortage specialist ... drugs we use ... read more

President Trump: Competition Is the Solution to High Drug Prices

The Food and Drug Administration (FDA) approval process is currently too slow, too costly, and too precautionary. This induces caution in drug companies, who constrict their development pipelines to l... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us